Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ADMP - Adamis Pharmaceuticals names co-founder David Marguglio as CEO

ADMP - Adamis Pharmaceuticals names co-founder David Marguglio as CEO

Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals (NASDAQ:ADMP) on Wednesday said it had appointed co-founder and chief business officer David Marguglio as its new president and CEO. Marguglio replaces Dennis Carlo, who has also stepped down from the board, effective immediately. Carlo led ADMP to three U.S. FDA product approvals. The leadership transition announcement comes two days after ADMP reported a better-than-expected Q1 revenue. ADMP stock down marginally in aftermarket trade. For the year to date, ADMP stock -29.8%.

For further details see:

Adamis Pharmaceuticals names co-founder David Marguglio as CEO
Stock Information
Company Name: Adamis Pharmaceuticals Corporation
Stock Symbol: ADMP
Market: NASDAQ
Website: adamispharmaceuticals.com
Menu
ADMP ADMP Quote ADMP Short ADMP News ADMP Articles ADMP Message Board
Get ADMP Alerts

News, Short Squeeze, Breakout and More Instantly...